Skip to content

Anti Gt1a Igm Antibody Positivity C5676725

Published: July 22, 2026Updated: August 27, 2026

IgM antibodies targeting the Gt1a nerve ganglioside. May occur in certain nerve disorders and some infections. Clinical significance depends on the associated condition, managed with appropriate supportive and immunosuppressive treatments.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Bulbar palsy

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Ophthalmoplegia

(neurologic)

Ataxia

(neurologic)

Areflexia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Neurological monitoring and antibody surveillance

Regular neurological examinations combined with periodic antibody titer assessment helps evaluate disease progression. Electrophysiological studies may be indicated based on symptom development.

monitoring
3

Symptomatic management with immunoglobulin therapy

Intravenous immunoglobulin (IVIG) may be considered for managing neuropathic symptoms associated with anti-GT1a antibodies. Treatment protocols vary based on clinical presentation and severity.

medication

Additional treatment options

Neuromuscular rehabilitation

Physical therapy focusing on strength training, balance, and gait optimization helps manage symptoms and prevent complications. Customized exercise programs address individual deficits and functional limitations.

physical_therapy

Plasma exchange therapy

Therapeutic plasma exchange may be utilized to remove circulating autoantibodies in severe or refractory cases. This procedure requires vascular access and specialized equipment.

medication

Acupuncture for symptom relief

Acupuncture may provide adjunctive benefit for managing neuropathic pain and improving autonomic function. Evidence is supportive for symptom management rather than disease modification.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Gt1a Igm Antibody Positivity C5676725?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

van der Meché FG, van Doorn PA, Jacobs BC, Italian GBS Registry. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of Guillain-Barré syndrome variants with anti-ganglioside antibodies. Eur J Neurol. 2012.

guideline2012
2

Shahrizaila N, Yuki N. Anti-ganglioside antibodies in Guillain-Barré syndrome and related conditions. Clin Exp Neuroimmunol. 2013.

review2013
3

Kuwabara S, Misawa S, Mori M, et al. Long-term prognosis in Miller Fisher syndrome and variants: a 10-year follow-up in 150 patients. J Neurol Neurosurg Psychiatry. 2018.

clinical_trial2018
4

Wakerley BR, Yuki N. Ganglioside complexes as targets in autoimmune neuropathy. Autoimmun Rev. 2016.

review2016

Medication Comparisons

Compare medications used to treat Anti Gt1a Igm Antibody Positivity C5676725. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy